Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer Article

Industry Collaboration International Collaboration

cited authors

  • Novello, S.; Scagliotti, G. V.; Rosell, R.; Socinski, M. A.; Brahmer, J.; Atkins, J.; Pallares, C.; Burgess, R.; Tye, L.; Selaru, P.; Wang, E.; Chao, R.; Govindan, R.

authors

Publication Date

  • October 27, 2009

webpage

published in

category

keywords

  • non-small cell lung cancer
  • phase II
  • sunitinib
  • tyrosine kinase inhibitor

start page

  • 1543

end page

  • 1548

volume

  • 101

issue

  • 9